Learn how MedTech companies are reigniting growth and expanding markets, with the industry's annual revenue growing for the seventh straight year, reaching almost US$600 billion for the first time.
The EY 2026 Firepower M&A report finds life sciences companies recognizing the need to accelerate their dealmaking strategies to succeed in an increasingly competitive environment.
As biopharma companies face a rapidly changing political landscape, we explore industry performance over the last year, including strategies that will position companies for long-term success.